Income Statement Biosynex

Stocks

ALBIO

FR0011005933

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 19:55:00 20/07/2026 +04			5-day change	1st Jan Change
0.9100 ^EUR	+2.02%		+2.71%	+52.68%

06-11	Triple update for Biosynex
06-11	An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million.	CI

5aea97ad7d3e8b0e1979aebebe8.Gu75rcN8NSBcVIlAjcMY8yE1WcArwq3jPs3Uv4LpjKE.dae6-o5Pf2sVIMYRy6dim28YALcareOoCPng5ejc9JJFlMvmlxphbzIs6g

Published financial data: BIOSYNEX

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	383M	197M	92.98M	101M	95.19M
Other Revenues, Total	-	-	-	-	-
Total Revenues	383M	197M	92.98M	101M	95.19M
Cost of Goods Sold, Total	176M	94.26M	43.85M	43.75M	42.84M
Gross Profit	206M	102M	49.13M	57.42M	52.36M
Selling General & Admin Expenses, Total	17.25M	21.44M	36.06M	41.38M	32.93M
Depreciation & Amortization - (IS)	6.61M	10.65M	24.62M	27.51M	34.55M
Amortization of Goodwill and Intangible Assets - (IS)	-	5.72M	-	-	-
Other Operating Expenses	41.9M	25.64M	24.6M	16.06M	10.93M
Other Operating Expenses, Total	65.76M	63.44M	85.28M	84.95M	78.4M
Operating Income	141M	38.88M	-36.15M	-27.53M	-26.05M
Interest Expense, Total	-347K	-501K	-2.08M	-2.96M	-4.44M
Interest And Investment Income	-	-	-	-	-
Net Interest Expenses	-347K	-501K	-2.08M	-2.96M	-4.44M
Income (Loss) On Equity Invest.	-2.68M	-5.57M	-1.51M	-99K	-168K
Currency Exchange Gains (Loss)	-	-	-	-	-96K
Other Non Operating Income (Expenses)	355K	755K	3M	-3.27M	1.52M
EBT, Excl. Unusual Items	138M	33.56M	-36.74M	-33.86M	-29.23M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-1.26M	-8.8M	-21.28M
Gain (Loss) On Sale Of Investments	-	-3.44M	-3.98M	-	5.73M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-1.04M	-5.93M	2.3M	-2.09M	-14.46M
EBT, Incl. Unusual Items	137M	24.18M	-39.68M	-44.75M	-59.24M
Income Tax Expense	32.94M	8.57M	-2.56M	-1.36M	-1.1M
Earnings From Continuing Operations	104M	15.61M	-37.12M	-43.4M	-58.14M
Net Income to Company	104M	15.61M	-37.12M	-43.4M	-58.14M
Minority Interest	-	43.66K	176K	64K	-82K
Net Income - (IS)	104M	15.66M	-36.95M	-43.33M	-58.22M
Net Income to Common Incl Extra Items	104M	15.66M	-36.95M	-43.33M	-58.22M
Net Income to Common Excl. Extra Items	104M	15.66M	-36.95M	-43.33M	-58.22M
Per Share Items
Net EPS - Basic	10.08	1.53	-3.45	-4.03	-3.16
Basic EPS - Continuing Operations	10.08	1.53	-3.45	-4.03	-3.16
Basic Weighted Average Shares Outstanding	10.32M	10.23M	10.71M	10.75M	18.43M
Net EPS - Diluted	10.01	1.52	-3.45	-4.03	-3.16
Diluted EPS - Continuing Operations	10.01	1.52	-3.45	-4.03	-3.16
Diluted Weighted Average Shares Outstanding	10.39M	10.3M	10.71M	10.75M	18.43M
Normalized Basic EPS	8.36	2.05	-2.13	-1.96	-1
Normalized Diluted EPS	8.3	2.04	-2.13	-1.96	-1
Dividend Per Share	2	-	-	-	-
Payout Ratio	1.86	130.57	-	-	-
Supplemental Items
EBITDA	142M	46.49M	-29.82M	-22.16M	-13.64M
EBITA	141M	45.01M	-33.19M	-25.4M	-20.18M
EBIT	141M	38.88M	-36.15M	-27.53M	-26.05M
EBITDAR	142M	46.77M	-29.54M	-	-
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	24.05	35.44	6.44	3.03	1.85
Normalized Net Income	86.24M	21.02M	-22.78M	-21.1M	-18.35M
Interest on Long-Term Debt	10.6K	4.03K	46K	-	-
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	3.54M	2.85M	3.92M	7.3M	5.34M
Net Rental Expense, Total	395K	289K	279K	-	-
Imputed Operating Lease Interest Expense	42.94K	26.55K	78.47K	-	-
Imputed Operating Lease Depreciation	352K	263K	201K	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	132M	87.17M	20.17M	4.69M	8.46M
Short Term Investments	-	-	6M	5M	-
Total Cash And Short Term Investments	132M	87.17M	26.16M	9.69M	8.46M
Accounts Receivable, Total	25.27M	14.7M	10.65M	7.1M	7.82M
Other Receivables	6.08M	14.09M	5.84M	6.21M	12.68M
Total Receivables	31.35M	28.79M	16.49M	13.31M	20.49M
Inventory	31.15M	37.67M	38.21M	32.66M	22.87M
Prepaid Expenses	1.05M	1.43M	2.93M	-	1.54M
Deferred Tax Assets Current	918K	1.2M	5.66M	4.55M	170K
Other Current Assets, Total	2.27M	3.35M	1.9M	4.18M	2.04M
Total Current Assets	199M	160M	91.35M	64.39M	55.56M
Gross Property Plant And Equipment	8.2M	10.61M	19.38M	38.13M	-
Accumulated Depreciation	-2.93M	-4.24M	-7.44M	-26.31M	-
Net Property Plant And Equipment	5.26M	6.38M	11.94M	11.82M	8.5M
Long-term Investments	3.28M	2.57M	470K	385K	371K
Goodwill	46.24M	60.91M	91.54M	64.13M	-
Other Intangibles, Total	5.89M	25.95M	39.8M	20.71M	69.24M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Charges Long-Term	-	-	-	28.11M	-
Other Long-Term Assets, Total	9.49M	4.93M	6.63M	5.13M	2.56M
Total Assets	269M	260M	242M	195M	136M
Liabilities
Accounts Payable, Total	18.73M	14.99M	15.07M	16.31M	17.15M
Accrued Expenses, Total	7.64M	6.62M	6.19M	8.15M	6M
Short-term Borrowings	53.86K	36.52K	239K	215K	-
Current Portion of Long-Term Debt	5.6M	6.05M	5.6M	46.98M	60.8M
Current Portion of Leases	498K	702K	552K	472K	462K
Current Income Taxes Payable	19.81M	1.73M	7K	7K	2.86M
Unearned Revenue Current, Total	1.94M	222K	510K	229K	141K
Deferred Tax Liability Current	567K	1.02M	3.48M	-	-
Other Current Liabilities	12.45M	8.36M	9.17M	5.33M	16K
Total Current Liabilities	67.29M	39.73M	40.82M	77.7M	87.42M
Long-Term Debt	28.62M	44.58M	58.28M	14.14M	-
Long-Term Leases	543K	708K	1.29M	819K	388K
Deferred Tax Liability Non Current	-	-	-	6.6M	1.13M
Other Non Current Liabilities	4.69M	8.43M	17.02M	14.94M	10.42M
Total Liabilities	101M	93.44M	117M	114M	99.35M
Common Stock, Total	1.11M	1.03M	1.08M	1.08M	1.88M
Additional Paid In Capital	47.27M	25.6M	25.6M	25.6M	32.78M
Retained Earnings	131M	77.08M	55.31M	73.8M	-58.22M
Comprehensive Income and Other	-11.5M	58.83M	42.49M	-19.9M	60.45M
Total Common Equity	168M	163M	124M	80.58M	36.89M
Minority Interest	-	4.37M	-165K	-81K	-
Total Equity	168M	167M	124M	80.5M	36.89M
Total Liabilities And Equity	269M	260M	242M	195M	136M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10.32M	10.25M	10.76M	18.75M	18.43M
ECS Total Common Shares Outstanding	10.32M	10.25M	10.76M	10.76M	18.43M
Book Value / Share	16.26	15.85	11.57	7.49	2
Tangible Book Value	116M	75.67M	-6.86M	-4.27M	-32.35M
Tangible Book Value Per Share	11.21	7.38	-0.64	-0.4	-1.76
Total Debt	35.31M	52.08M	65.96M	62.63M	61.64M
Net Debt	-96.72M	-35.09M	39.8M	52.94M	53.19M
Debt Equivalent of Unfunded Proj. Benefit Obligation	243K	180K	282K	312K	246K
Debt Equivalent Oper. Leases	3.16M	2.31M	2.23M	-	-
Minority Interest, Total (Incl. Fin. Div)	-	4.37M	-165K	-81K	-
Equity Method Investments, Total	-	1.57M	470K	385K	217K
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	15.2M	18.55M	24.64M	20.24M	-
Inventories - Work In Process, Total	-	-	-	-	6.7M
Inventories - Finished Goods, Total	19.35M	27.05M	31.43M	25.59M	15.52M
Inventories - Others	-	-	-	-	14.17M
Buildings, Total	-	-	90K	3.87M	-
Machinery, Total	6.37M	10.58M	19.27M	34.26M	-
Full Time Employees	260	367	569	476	397
Accumulated Allowance for Doubtful Accounts (Supple)	489K	309K	1.07M	1.1M	883K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	104M	15.66M	-36.95M	-43.33M	-58.22M
Depreciation & Amortization - CF	989K	1.48M	3.37M	3.24M	6.54M
Amortization of Goodwill and Intangible Assets - (CF)	152K	6.12M	2.96M	2.13M	5.87M
Depreciation & Amortization, Total	1.14M	7.6M	6.32M	5.37M	12.41M
Amortization of Deferred Charges, Total - (CF)	1.77M	2.85M	3.97M	7.31M	16.34M
(Gain) Loss From Sale Of Asset	30.87K	-7.56K	-17K	565K	-7.35M
Asset Writedown & Restructuring Costs	-	-	-	8.8M	21.28M
Other Operating Activities, Total	2.31M	16.1M	2.51M	-1.74M	2.85M
Change in Other Net Operating Assets	578K	-37.26M	14.51M	12.9M	6.8M
Cash from Operations	110M	4.95M	-9.65M	-10.12M	-5.89M
Capital Expenditure	-19.02M	-30.08M	-39.54M	-4.84M	-2.68M
Sale of Property, Plant, and Equipment	42.18K	51.83K	77K	1.25M	769K
Cash Acquisitions	-10.96M	-9.74M	-16.05M	-1.01M	-46K
Investment in Marketable and Equity Securities, Total	-	-	-	-	5.01M
Other Investing Activities, Total	970K	686K	706K	-	-1K
Cash from Investing	-28.96M	-39.08M	-54.81M	-4.6M	3.04M
Short Term Debt Issued, Total	-	-	-	-	8K
Long-Term Debt Issued, Total	24.25M	17.66M	22.41M	159K	-
Total Debt Issued	24.25M	17.66M	22.41M	159K	8K
Long-Term Debt Repaid, Total	-7.42M	-5.57M	-14.83M	-4.25M	-990K
Total Debt Repaid	-7.42M	-5.57M	-14.83M	-4.25M	-990K
Issuance of Common Stock	19.43M	-	-	-	7.99M
Repurchase of Common Stock	-20.08M	-1.73M	-3.22M	-	-
Common Dividends Paid	-1.94M	-20.44M	-	-	-
Common & Preferred Stock Dividends Paid	-1.94M	-20.44M	-	-	-
Other Financing Activities, Total	158K	-729K	808K	3.29M	-100K
Cash from Financing	14.4M	-10.81M	5.17M	-801K	6.9M
Foreign Exchange Rate Adjustments	-	-	-	-	-254K
Net Change in Cash	95.27M	-44.95M	-59.3M	-15.52M	3.81M
Supplemental Items
Levered Free Cash Flow	73.61M	-29.53M	-44.39M	-1.64M	14.17M
Unlevered Free Cash Flow	73.83M	-29.22M	-43.1M	210K	16.95M
Change In Net Working Capital	-2.03M	33.89M	-8.74M	-9.57M	-7.16M
Net Debt Issued / Repaid	16.83M	12.09M	7.58M	-4.09M	-982K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	44.51	9.18	-9	-7.89	-9.84
Return on Total Capital	61.65	11.51	-11.04	-10.32	-13.26
Return On Equity %	88.86	9.33	-25.49	-42.38	-95.94
Return on Common Equity	88.86	9.48	-25.75	-42.26	-96.01
Margin Analysis
Gross Profit Margin %	53.96	52.05	52.84	56.76	55
SG&A Margin	4.51	10.9	38.78	40.9	34.59
EBITDA Margin %	37.07	23.65	-32.07	-21.9	-14.33
EBITA Margin %	36.81	22.89	-35.7	-25.11	-21.2
EBIT Margin %	36.77	19.78	-38.88	-27.22	-27.36
Income From Continuing Operations Margin %	27.19	7.94	-39.93	-42.9	-61.08
Net Income Margin %	27.19	7.96	-39.74	-42.83	-61.16
Net Avail. For Common Margin %	27.19	7.96	-39.74	-42.83	-61.16
Normalized Net Income Margin	22.54	10.69	-24.5	-20.85	-19.28
Levered Free Cash Flow Margin	19.24	-15.02	-47.75	-1.62	14.89
Unlevered Free Cash Flow Margin	19.3	-14.86	-46.35	0.21	17.8
Asset Turnover
Asset Turnover	1.94	0.74	0.37	0.46	0.58
Fixed Assets Turnover	100.36	40.06	10.15	8.52	9.37
Receivables Turnover (Average Receivables)	20.82	9.84	7.34	11.4	12.76
Inventory Turnover (Average Inventory)	5.53	2.74	1.16	1.23	1.54
Short Term Liquidity
Current Ratio	2.95	4.02	2.24	0.83	0.64
Quick Ratio	2.43	2.92	1.04	0.3	0.33
Operating Cash Flow to Current Liabilities	1.63	0.12	-0.24	-0.13	-0.07
Days Sales Outstanding (Average Receivables)	17.53	37.1	49.76	32.11	28.59
Days Outstanding Inventory (Average Inventory)	66.01	133.25	315.86	296.49	236.59
Average Days Payable Outstanding	40.02	61.06	123.61	150.36	184.8
Cash Conversion Cycle (Average Days)	43.52	109.3	242	178.24	80.38
Long Term Solvency
Total Debt/Equity	21.04	31.2	53.06	77.8	167.11
Total Debt / Total Capital	17.38	23.78	34.67	43.76	62.56
LT Debt/Equity	17.38	27.13	47.92	18.59	1.05
Long-Term Debt / Total Capital	14.36	20.68	31.31	10.45	0.39
Total Liabilities / Total Assets	37.61	35.89	48.57	58.65	72.92
EBIT / Interest Expense	405.67	77.57	-17.42	-9.31	-5.87
EBITDA / Interest Expense	408.96	92.74	-14.37	-7.49	-3.07
(EBITDA - Capex) / Interest Expense	354.11	32.73	-33.43	-9.13	-3.68
Total Debt / EBITDA	0.25	1.12	-2.21	-2.83	-4.52
Net Debt / EBITDA	-0.68	-0.75	-1.33	-2.39	-3.9
Total Debt / (EBITDA - Capex)	0.29	3.17	-0.95	-2.32	-3.78
Net Debt / (EBITDA - Capex)	-0.79	-2.14	-0.57	-1.96	-3.26
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	148.57	-48.61	-52.7	8.81	-5.9
Gross Profit, 1 Yr. Growth %	197.77	-50.43	-51.98	16.87	-8.82
EBITDA, 1 Yr. Growth %	167.63	-67.42	-149.5	-7.46	-13.66
EBITA, 1 Yr. Growth %	207.88	-68	-174.41	-29.73	-26.7
EBIT, 1 Yr. Growth %	207.54	-72.36	-192.96	-23.83	-5.39
Earnings From Cont. Operations, 1 Yr. Growth %	231.54	-84.99	-337.76	16.9	33.97
Net Income, 1 Yr. Growth %	231.54	-84.95	-335.97	17.28	34.36
Normalized Net Income, 1 Yr. Growth %	209.89	-75.63	-208.39	-7.41	-4.89
Diluted EPS Before Extra, 1 Yr. Growth %	184.38	-84.82	-326.97	16.81	-21.62
Accounts Receivable, 1 Yr. Growth %	119.95	-41.82	-27.56	-33.33	10.07
Inventory, 1 Yr. Growth %	-4.29	20.94	1.43	-14.51	-29.99
Net Property, Plant and Equip., 1 Yr. Growth %	123.18	85.5	87.16	-0.93	-28.08
Total Assets, 1 Yr. Growth %	113.32	-3.2	-7.15	-19.46	-30.02
Tangible Book Value, 1 Yr. Growth %	223.71	-34.58	-109.07	-138.18	7.12K
Common Equity, 1 Yr. Growth %	153.14	-3.14	-23.41	-35.27	-56.29
Cash From Operations, 1 Yr. Growth %	247.17	-95.5	-295.23	4.84	-41.81
Capital Expenditures, 1 Yr. Growth %	108.56	58.19	4.69	-87.76	-44.52
Levered Free Cash Flow, 1 Yr. Growth %	173.69	-140.6	68.72	-96.44	-326.21
Unlevered Free Cash Flow, 1 Yr. Growth %	173.08	-140.05	65.77	-100.47	-505.1
Dividend Per Share, 1 Yr. Growth %	900	-	-	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	229.78	13.02	-50.7	-28.26	1.18
Gross Profit, 2 Yr. CAGR %	225.83	21.5	-51.21	-25.09	3.23
EBITDA, 2 Yr. CAGR %	629.22	-6.33	-54.28	-39.35	-24.52
EBITA, 2 Yr. CAGR %	838.76	-0.8	-51.42	-24.54	-25.28
EBIT, 2 Yr. CAGR %	838.25	-7.79	-49.31	-15.85	-15.11
Earnings From Cont. Operations, 2 Yr. CAGR %	873.23	-29.45	-40.26	66.72	25.15
Net Income, 2 Yr. CAGR %	873.23	-29.35	-40.4	66.36	25.54
Normalized Net Income, 2 Yr. CAGR %	856.67	-13.09	-48.6	0.18	-10.25
Diluted EPS Before Extra, 2 Yr. CAGR %	813.33	-34.29	-41.29	62.83	-4.31
Accounts Receivable, 2 Yr. CAGR %	198.82	13.12	-35.08	-30.5	-14.33
Inventory, 2 Yr. CAGR %	99.56	7.59	10.75	-6.88	-22.64
Net Property, Plant and Equip., 2 Yr. CAGR %	129.68	64.42	86.33	36.17	-15.59
Total Assets, 2 Yr. CAGR %	139.21	43.7	-5.19	-13.52	-24.93
Tangible Book Value, 2 Yr. CAGR %	740.22	45.52	-75.64	-76.25	70.15
Common Equity, 2 Yr. CAGR %	134.47	56.58	-13.87	-29.59	-45.56
Cash From Operations, 2 Yr. CAGR %	-	-60.46	-70.35	43.06	-21.9
Capital Expenditures, 2 Yr. CAGR %	-	81.64	44.21	-64.2	-73.94
Levered Free Cash Flow, 2 Yr. CAGR %	-	4.78	-21.88	-75.05	-44.48
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	3.95	-23.14	-91.02	-38.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	130.35	77.47	-15.46	-35.81	-21.47
Gross Profit, 3 Yr. CAGR %	186.71	73.94	-10.84	-34.72	-20.02
EBITDA, 3 Yr. CAGR %	452.91	159.29	-17.43	-46.25	-39.05
EBITA, 3 Yr. CAGR %	623.52	204.26	-10.13	-43.48	-23.23
EBIT, 3 Yr. CAGR %	623.26	189.79	-7.54	-41.94	-12.5
Earnings From Cont. Operations, 3 Yr. CAGR %	476.47	142.27	5.77	-25.28	55
Net Income, 3 Yr. CAGR %	476.47	142.49	5.61	-25.31	54.93
Normalized Net Income, 3 Yr. CAGR %	748.69	181.5	-6.45	-37.46	-4.43
Diluted EPS Before Extra, 3 Yr. CAGR %	452.27	133.11	-0.67	-26.16	27.61
Accounts Receivable, 3 Yr. CAGR %	104.76	73.19	-2.5	-34.5	-18.99
Inventory, 3 Yr. CAGR %	70.94	68.87	5.49	1.59	-15.33
Net Property, Plant and Equip., 3 Yr. CAGR %	125.29	85.57	71.68	50.95	10.07
Total Assets, 3 Yr. CAGR %	89.6	76.93	24.23	-10.21	-19.41
Tangible Book Value, 3 Yr. CAGR %	183.17	258.78	-42.3	-66.71	-24.66
Common Equity, 3 Yr. CAGR %	78.99	74.62	23.37	-21.69	-39
Cash From Operations, 3 Yr. CAGR %	-	-	-32.68	-54.83	6
Capital Expenditures, 3 Yr. CAGR %	-	-	63.08	-36.63	-58.58
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	18.18	-71.76	-18.64
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	16.82	-85.78	-13.3
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	69.75	45.06	24.33	23.53	-9.16
Gross Profit, 5 Yr. CAGR %	99.57	64.36	41.18	24.18	-5.46
EBITDA, 5 Yr. CAGR %	155.94	101.29	104.25	52.73	-23.77
EBITA, 5 Yr. CAGR %	181.18	117.63	145.56	73.88	-15.09
EBIT, 5 Yr. CAGR %	181.11	111.36	149.78	76.71	-10.65
Earnings From Cont. Operations, 5 Yr. CAGR %	286.82	118.26	132.8	108.62	13.13
Net Income, 5 Yr. CAGR %	286.82	118.38	132.58	108.56	13.17
Normalized Net Income, 5 Yr. CAGR %	210.9	112.82	176.46	86.21	-7.99
Diluted EPS Before Extra, 5 Yr. CAGR %	267.57	113.2	125.3	101.94	-2.14
Accounts Receivable, 5 Yr. CAGR %	36.35	33.78	29.33	20.2	-7.42
Inventory, 5 Yr. CAGR %	38.95	42.07	43.7	33.09	-6.81
Net Property, Plant and Equip., 5 Yr. CAGR %	60.48	67.55	91.75	63.96	29.24
Total Assets, 5 Yr. CAGR %	46.76	45.08	43.69	32.88	1.56
Tangible Book Value, 5 Yr. CAGR %	383.08	76.21	6.14	21.1	-1.97
Common Equity, 5 Yr. CAGR %	47.1	41.25	33.58	21.43	-11.06
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	-28.56
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	-21.69
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-12.03
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-8.92